White & Case Defeats Motion for Class Certification on Behalf of Par Pharmaceutical Companies and Paddock Holdings

Global law firm White & Case LLP, on behalf of clients Par Pharmaceutical Companies, Inc. and Paddock Holdings, LLC, defeated direct-purchaser plaintiffs' motion for class certification in the In re AndroGel Antitrust Litigation multi-district litigation proceeding in the US District Court for the Northern District of Georgia. 

White & Case partners Eric Grannon and Adam Acosta, based in the Firm's Washington, DC office, were counsel on the brief in opposition to class certification, and the court's order cited the White & Case brief and appendix several times. In re AndroGel are the private cases that parallel the FTC v. Actavis case that resulted in the US Supreme Court’s seminal 2013 decision of the same name, and in which White & Case acted as counsel of record for the same clients before the Supreme Court.

"It's gratifying that the court evidently found our brief and appendix that provided detailed background on each of the putative class members useful in reaching the decision to deny class certification," said White & Case antitrust partner Eric Grannon. "This appears to be only the second time that direct-purchaser plaintiffs have been denied class certification in a reverse payment case in the 20 or so years these cases have been litigated."

Press contact
For more information, please speak to your local media contact.